Comparison of the overall survival and recurrence rates between DDLT and LDLT in the salvage LT group.

The recurrence-free survival (figure 1a) and long-term survival (figure 1b) curves for all of the patients.

Chuan Li (158692)
Tian-Fu Wen (448789)
Lu-Nan Yan (448790)
Bo Li (112195)
Jia-Ying Yang (448791)
Ming-Qing Xu (448792)
Wen-Tao Wang (448793)
Yong-Gang Wei (220791)

August 2013

Recurrence-free survival (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...

Comparison of clinical features among patients in the survival and death subgroups of the verification group (% or range).

Guomei Xia (13891020)
Shanshan Sun (275585)
Shijun Zhou (11185840)
Lei Li (29537)
Xu Li (23864)
Guizhou Zou (7216184)
Cheng Huang (115619)
Jun Li (6494)
Zhenhua Zhang (562631)

March 2023

Comparison of clinical features among patients in the survival and death subgroups of the verificati...

Comparison of recurrence-free survival rates in the low (<2.14) and high (≥2.14) NLR groups.

Xin Li (51274)
Zhiyu Han (647367)
Zhigang Cheng (647368)
Jie Yu (150626)
Shirong Liu (208560)
Xiaoling Yu (354738)
Ping Liang (30204)

October 2014

The recurrence-free survival rate was significantly higher in the low NLR group than in the high ...

Comparison of the overall survival and recurrence rates between primary and salvage LT groups.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Comparison of the overall survival and recurrence rates between LR and primary LT groups.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Comparison of the overall survival and recurrence rates in the salvage LT group according to the Milan criteria.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Survival curves of patients undergoing LDLT versus DDLT (P = 0.400).

Chuan Li (158692)
Kai Mi (340061)
Tian fu Wen (5652679)
Lu nan Yan (5652682)
Bo Li (112195)
Jia ying Yang (340063)
Ming qing Xu (340064)
Wen tao Wang (340065)
Yong gang Wei (340066)

February 2013

Survival curves of patients undergoing LDLT versus DDLT (P = 0.400).</p

Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.

Marek Szymczak (4885087)
Piotr Kaliciński (4885093)
Grzegorz Kowalewski (4885090)
Dorota Broniszczak (4885099)
Małgorzata Markiewicz-Kijewska (4885096)
Hor Ismail (4885108)
Marek Stefanowicz (4885105)
Adam Kowalski (4593751)
Joanna Teisseyre (4885102)
Irena Jankowska (4885084)
Waldemar Patkowski (107310)

February 2018

Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.</p

Figure 2

LinWei Wu (5651992)
AnBin Hu (313928)
Ngalei Tam (313929)
JianWei Zhang (5651995)
Min Lin (17652)
ZhiYong Guo (5651998)
XiaoShun He (5652001)

February 2013

(A) shows the cumulative recurrence rate between SLT group and PLTW group, a Log-Rank test showed...

Figure 1

LinWei Wu (5651992)
AnBin Hu (313928)
Ngalei Tam (313929)
JianWei Zhang (5651995)
Min Lin (17652)
ZhiYong Guo (5651998)
XiaoShun He (5652001)

February 2013

(A) shows the cumulative survival rate between SLT group and PLTW group, a Log-Rank test showed <...

Comparison of survival curves among the patients according to the sT and pT category.

Ji-wang Liang (5651563)
Peng Gao (35465)
Zhen-ning Wang (149288)
Yong-xi Song (149290)
Ying-ying Xu (149293)
Mei-xian Wang (292174)
Yu-lan Dong (292176)
Hui-mian Xu (149296)

February 2013

A, Survival curves of patients with different sT categories. B, Survival curves of ...

A comparison of recurrence between LC and non-LC group except patients with TNM stage IV.

Eon Chul Han (4090432)
Seung-Bum Ryoo (4090429)
Ji Won Park (285375)
Jin Wook Yi (3154902)
Heung-Kwon Oh (728441)
Eun Kyung Choe (4090423)
Heon-Kyun Ha (4090420)
Byung Kwan Park (4090426)
Sang Hui Moon (4090435)
Seung-Yong Jeong (414029)
Kyu Joo Park (414030)

June 2017

A comparison of recurrence between LC and non-LC group except patients with TNM stage IV.</p

HBV recurrence curve in patients undergoing LDLT versus DDLT (P = 0.220).

Chuan Li (158692)
Kai Mi (340061)
Tian fu Wen (5652679)
Lu nan Yan (5652682)
Bo Li (112195)
Jia ying Yang (340063)
Ming qing Xu (340064)
Wen tao Wang (340065)
Yong gang Wei (340066)

February 2013

HBV recurrence curve in patients undergoing LDLT versus DDLT (P = 0.220).</p

Comparison of patient cumulative survivals.

Qi Ling (187076)
Xiao Xu (112147)
Qiang Wei (187077)
Xiaoli Liu (165371)
Haijun Guo (187078)
Li Zhuang (120307)
Jiajia Chen (187079)
Qi Xia (187080)
Haiyang Xie (187082)
Jian Wu (41301)
Shusen Zheng (187083)
Lanjuan Li (112956)

January 2012

Kaplan-Meier analysis was used to compare survivals between patients underwent LDLT and those rec...

Comparison of Clinical Features of Patients with SFTS in the Survival and Death Subgroups of the Modeling Group (% or Range).

Guomei Xia (13891020)
Shanshan Sun (275585)
Shijun Zhou (11185840)
Lei Li (29537)
Xu Li (23864)
Guizhou Zou (7216184)
Cheng Huang (115619)
Jun Li (6494)
Zhenhua Zhang (562631)

March 2023

Comparison of Clinical Features of Patients with SFTS in the Survival and Death Subgroups of the Mod...

The recurrence-free survival (figure 1a) and long-term survival (figure 1b) curves for all of the patients.

Chuan Li (158692)
Tian-Fu Wen (448789)
Lu-Nan Yan (448790)
Bo Li (112195)
Jia-Ying Yang (448791)
Ming-Qing Xu (448792)
Wen-Tao Wang (448793)
Yong-Gang Wei (220791)

August 2013

Recurrence-free survival (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...

Comparison of clinical features among patients in the survival and death subgroups of the verification group (% or range).

Guomei Xia (13891020)
Shanshan Sun (275585)
Shijun Zhou (11185840)
Lei Li (29537)
Xu Li (23864)
Guizhou Zou (7216184)
Cheng Huang (115619)
Jun Li (6494)
Zhenhua Zhang (562631)

March 2023

Comparison of clinical features among patients in the survival and death subgroups of the verificati...

Comparison of recurrence-free survival rates in the low (<2.14) and high (≥2.14) NLR groups.

Xin Li (51274)
Zhiyu Han (647367)
Zhigang Cheng (647368)
Jie Yu (150626)
Shirong Liu (208560)
Xiaoling Yu (354738)
Ping Liang (30204)

October 2014

The recurrence-free survival rate was significantly higher in the low NLR group than in the high ...

Comparison of the overall survival and recurrence rates between primary and salvage LT groups.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Comparison of the overall survival and recurrence rates between LR and primary LT groups.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Comparison of the overall survival and recurrence rates in the salvage LT group according to the Milan criteria.

Fei Liu (21082)
Yonggang Wei (120527)
Wentao Wang (120529)
Kefei Chen (24659)
Lvnan Yan (120531)
Tianfu Wen (120533)
Jichun Zhao (120536)
Mingqing Xu (120539)
Bo Li (112195)

November 2012

Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...

Survival curves of patients undergoing LDLT versus DDLT (P = 0.400).

Chuan Li (158692)
Kai Mi (340061)
Tian fu Wen (5652679)
Lu nan Yan (5652682)
Bo Li (112195)
Jia ying Yang (340063)
Ming qing Xu (340064)
Wen tao Wang (340065)
Yong gang Wei (340066)

February 2013

Survival curves of patients undergoing LDLT versus DDLT (P = 0.400).</p

Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.

Marek Szymczak (4885087)
Piotr Kaliciński (4885093)
Grzegorz Kowalewski (4885090)
Dorota Broniszczak (4885099)
Małgorzata Markiewicz-Kijewska (4885096)
Hor Ismail (4885108)
Marek Stefanowicz (4885105)
Adam Kowalski (4593751)
Joanna Teisseyre (4885102)
Irena Jankowska (4885084)
Waldemar Patkowski (107310)

February 2018

Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.</p

Figure 2

LinWei Wu (5651992)
AnBin Hu (313928)
Ngalei Tam (313929)
JianWei Zhang (5651995)
Min Lin (17652)
ZhiYong Guo (5651998)
XiaoShun He (5652001)

February 2013

(A) shows the cumulative recurrence rate between SLT group and PLTW group, a Log-Rank test showed...

Figure 1

LinWei Wu (5651992)
AnBin Hu (313928)
Ngalei Tam (313929)
JianWei Zhang (5651995)
Min Lin (17652)
ZhiYong Guo (5651998)
XiaoShun He (5652001)

February 2013

(A) shows the cumulative survival rate between SLT group and PLTW group, a Log-Rank test showed <...

Comparison of survival curves among the patients according to the sT and pT category.

Ji-wang Liang (5651563)
Peng Gao (35465)
Zhen-ning Wang (149288)
Yong-xi Song (149290)
Ying-ying Xu (149293)
Mei-xian Wang (292174)
Yu-lan Dong (292176)
Hui-mian Xu (149296)

February 2013

A, Survival curves of patients with different sT categories. B, Survival curves of ...

A comparison of recurrence between LC and non-LC group except patients with TNM stage IV.

Eon Chul Han (4090432)
Seung-Bum Ryoo (4090429)
Ji Won Park (285375)
Jin Wook Yi (3154902)
Heung-Kwon Oh (728441)
Eun Kyung Choe (4090423)
Heon-Kyun Ha (4090420)
Byung Kwan Park (4090426)
Sang Hui Moon (4090435)
Seung-Yong Jeong (414029)
Kyu Joo Park (414030)

June 2017

A comparison of recurrence between LC and non-LC group except patients with TNM stage IV.</p

HBV recurrence curve in patients undergoing LDLT versus DDLT (P = 0.220).

Chuan Li (158692)
Kai Mi (340061)
Tian fu Wen (5652679)
Lu nan Yan (5652682)
Bo Li (112195)
Jia ying Yang (340063)
Ming qing Xu (340064)
Wen tao Wang (340065)
Yong gang Wei (340066)

February 2013

HBV recurrence curve in patients undergoing LDLT versus DDLT (P = 0.220).</p

Comparison of patient cumulative survivals.

Qi Ling (187076)
Xiao Xu (112147)
Qiang Wei (187077)
Xiaoli Liu (165371)
Haijun Guo (187078)
Li Zhuang (120307)
Jiajia Chen (187079)
Qi Xia (187080)
Haiyang Xie (187082)
Jian Wu (41301)
Shusen Zheng (187083)
Lanjuan Li (112956)

January 2012

Kaplan-Meier analysis was used to compare survivals between patients underwent LDLT and those rec...

Comparison of Clinical Features of Patients with SFTS in the Survival and Death Subgroups of the Modeling Group (% or Range).

Guomei Xia (13891020)
Shanshan Sun (275585)
Shijun Zhou (11185840)
Lei Li (29537)
Xu Li (23864)
Guizhou Zou (7216184)
Cheng Huang (115619)
Jun Li (6494)
Zhenhua Zhang (562631)

March 2023

Comparison of Clinical Features of Patients with SFTS in the Survival and Death Subgroups of the Mod...

The recurrence-free survival (figure 1a) and long-term survival (figure 1b) curves for all of the patients.

Chuan Li (158692)
Tian-Fu Wen (448789)
Lu-Nan Yan (448790)
Bo Li (112195)
Jia-Ying Yang (448791)
Ming-Qing Xu (448792)
Wen-Tao Wang (448793)
Yong-Gang Wei (220791)

August 2013

Recurrence-free survival (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...

Comparison of clinical features among patients in the survival and death subgroups of the verification group (% or range).

Guomei Xia (13891020)
Shanshan Sun (275585)
Shijun Zhou (11185840)
Lei Li (29537)
Xu Li (23864)
Guizhou Zou (7216184)
Cheng Huang (115619)
Jun Li (6494)
Zhenhua Zhang (562631)

March 2023

Comparison of clinical features among patients in the survival and death subgroups of the verificati...

Comparison of recurrence-free survival rates in the low (<2.14) and high (≥2.14) NLR groups.

Xin Li (51274)
Zhiyu Han (647367)
Zhigang Cheng (647368)
Jie Yu (150626)
Shirong Liu (208560)
Xiaoling Yu (354738)
Ping Liang (30204)

October 2014

The recurrence-free survival rate was significantly higher in the low NLR group than in the high ...

Comparison of the overall survival and recurrence rates between DDLT and LDLT in the salvage LT group.

Abstract

Extracted data

Comparison of the overall survival and recurrence rates between DDLT and LDLT in the salvage LT group.

Abstract

Extracted data

Related items

Related items